Ledger.Open graph →
SEC Form D · filed November 26, 2018

Harpoon Therapeutics, Inc

Offering
$70.0M
Sold
$70.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Jonathan R. Drachman · South San Francisco, CADirectorJulie R. Eastland · South San Francisco, CADirectorMark R. Chin · South San Francisco, CADirectorScott R. Myers · South San Francisco, CADirectorRon R. Hunt · South San Francisco, CADirectorLuke R. Evnin · South San Francisco, CADirectorNatalie R. Sacks · South San Francisco, CAExecPatrick R. Baeuerle · South San Francisco, CADirectorHolger R. Wesche · South San Francisco, CAExecGerald Mcmahon · New Haven, CTExec · DirectorGeorgia L. Erbez · South San Francisco, CAExecJonathan R. Drachman · South San Francisco, CADirectorNatalie R. Sacks · South San Francisco, CAExecJulie R. Eastland · South San Francisco, CADirectorPatrick R. Baeuerle · South San Francisco, CADirectorMark R. Chin · South San Francisco, CADirectorHolger R. Wesche · South San Francisco, CAExecGerald Mcmahon · New Haven, CTExec · DirectorScott R. Myers · South San Francisco, CADirectorRon R. Hunt · South San Francisco, CADirectorGeorgia L. Erbez · South San Francisco, CAExecLuke R. Evnin · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗